CARL ZEISS MEDITEC AG

Bid 61,25 EUR
Ask 61,75 EUR

Premiumpartner

Firmenbeschreibung

Unter dem Schirm der Carl Zeiss Meditec AG sind die Medizintechnik-Aktivitäten von ZEISS gebündelt. Das Unternehmen ist einer der weltweit führenden Medizintechnik-Anbieter. Die Gesellschaft bietet Lösungen für die Zukunftsmärkte Medical and Research Solutions, Industrial Solutions, Eye Care und Lifestyle Products an und trägt mit Innovationen in der Augenheilkunde und Mikrochirurgie zum medizinischen Fortschritt bei. Das Unternehmen entwickelt und vertreibt Operationsmikroskope, ophthalmologische Diagnosesysteme, Mikroskope, Lithografieoptik, industrielle Messtechnik, Brillengläser, Planetariumstechnik, optronische Produkte, Film- und Fotoobjektive sowie Ferngläser und Spektive. Ärzte in aller Welt bekommen mit Zeiss-Meditec-Technologien intelligente Werkzeuge an die Hand, um die vier wesentlichen Krankheitsbilder des Auges, Fehlsichtigkeit (Refraktion), Grauer Star (Katarakt), Grüner Star (Glaukom) und Netzhauterkrankungen (Retina-Erkrankungen), effizient und wirksam zu behandeln und bietet dabei Produkte von der Diagnose über die Therapie bis hin zur Nachbehandlung. Darüber hinaus bietet der Konzern neben Operationsmikroskopen auch Visualisierungslösungen für die HNO- und Neurochirurgie. Die Produkte werden dabei in erster Linie bei der Entfernung von Tumoren, der Behandlung von Gefäßerkrankungen und bei der Therapie funktioneller Krankheiten eingesetzt.

KeyData

endOfFinancialYear: 30.09.2023 00:00
stockholderStructure: Carl Zeiss AG und Carl Zeiss Inc. (59.14%)
sharesOutstanding: 89440570.0000
ceo: Dr. Markus Weber
board: Justus Felix Wehmer
supervisoryBoard: Dr. Karl Lamprecht, Isabel De Paoli, Tanja von der Goltz, Peter Kameritsch, Dr. Christian Müller, Torsten Reitze, Renè Denner, Brigitte Koblizek, Jeffrey Marx , Heike Madan, Falk Bindheim, Dr. Christian Münster
countryID: 2
freeFloat: 40.9000
faceValue: 1.0000
faceValueCurrencyID: 1
faceValueCurrency: EUR
sectorName: Medizintechnische Produkte
industryName: Gesundheitswesen
subsectorName: Hochentwickelte medizinische Geräte
country: Deutschland
countryName: Deutschland

Kontakt

name: Sebastian Frericks
phone: +49-3641-220-116
fax: +49-3641-220-117
email: investors.meditec@zeiss.com
irWebSite: https://www.zeiss.com/meditec-ag/investor-relations.html#contact

Adresse

street: Göschwitzer Straße 51-52
city: D-07745 Jena
phone: +49-3641-220-0
fax: +49 3641 220 112
webSite: zeiss.de/corporate/home.html
email: info@meditec.zeiss.com

Finanzen (kurz)

year: 2021 cash: 7.4000
balanceSheetTotal: 2396.0000 liabilities: 718.6000
totalShareholdersEquity: 1659.3000 sales: 1646.8000
investment: 1.6000 incomeBeforeTaxes: 339.1000
netIncome: 236.3000 cashFlow: 1.2000
employees: 3531 currencyID: 1
units: 1000000 currency: EUR
year: 2022 cash: 7.7300
balanceSheetTotal: 2822.8200 liabilities: 792.7300
totalShareholdersEquity: 2015.1000 sales: 1902.8400
investment: 13.2500 incomeBeforeTaxes: 403.4900
netIncome: 293.9000 employees: 4224
currencyID: 1 units: 1000000
currency: EUR
year: 2023 cash: 10.6000
balanceSheetTotal: 3032.9000 liabilities: 860.0100
totalShareholdersEquity: 2159.4000 sales: 2089.3000
investment: 28.1000 incomeBeforeTaxes: 412.6000
netIncome: 290.4000 employees: 4823
currencyID: 1 units: 1000000
currency: EUR

Finanzen (kurz)

year: 2021
cash: 7.4000
balanceSheetTotal: 2396.0000
liabilities: 718.6000
totalShareholdersEquity: 1659.3000
sales: 1646.8000
investment: 1.6000
incomeBeforeTaxes: 339.1000
netIncome: 236.3000
cashFlow: 1.2000
employees: 3531
currencyID: 1
units: 1000000
currency: EUR
year: 2022
cash: 7.7300
balanceSheetTotal: 2822.8200
liabilities: 792.7300
totalShareholdersEquity: 2015.1000
sales: 1902.8400
investment: 13.2500
incomeBeforeTaxes: 403.4900
netIncome: 293.9000
employees: 4224
currencyID: 1
units: 1000000
currency: EUR
year: 2023
cash: 10.6000
balanceSheetTotal: 3032.9000
liabilities: 860.0100
totalShareholdersEquity: 2159.4000
sales: 2089.3000
investment: 28.1000
incomeBeforeTaxes: 412.6000
netIncome: 290.4000
employees: 4823
currencyID: 1
units: 1000000
currency: EUR

Finanzen (ausführlich)

year: 2022 units: 1000000
balanceSheetTotal: 2822.8200 cash: 7.7300
currentAssets: 1791.8500 fixedAssets: 1030.9600
liabilities: 539.3200 nonCurrentLiabilities: 253.4100
totalLiabilitiesEquity: 2822.8200 provisions: 29.3100
totalShareholdersEquity: 2015.1000 employees: 4224
property: 236.1500 intangibleAssets: 240.4300
inventories: 382.7500 accountsReceivable: 197.8000
accountsPayable: 124.3900 liabilitiesTotal: 792.7300
longTermDebt: 91.7700 shortTermDebt: 66.8800
minorityInterests: 14.9900 sales: 1902.8400
depreciation: 69.7700 netIncome: 293.9000
operatingResult: 396.8800 incomeInterest: 4.1500
investments: 291.3700 incomeTaxes: 107.5800
costGoodsSold: 775.2400 grossProfit: 1127.6000
minorityInterestsProfit: -2.0000 revenuePerEmployee: 450482.9545
cashFlow: 188.2000 cashFlowInvesting: -148.8900
cashFlowFinancing: -38.2400 accountingStandard: IFRS
equityRatio: 71.3861 debtEquityRatio: 40.0834
liquidityI: 1.4333 liquidityII: 38.1091
netMargin: 15.4453 grossMargin: 59.2588
cashFlowMargin: 9.8905 ebitMargin: 20.8572
ebitdaMargin: 0.0000 preTaxROE: 20.0233
preTaxROA: 14.2939 roe: 14.5849
roa: 10.4116 netIncomeGrowth: 24.3758
revenuesGrowth: 15.5477 taxExpenseRate: 26.6624
equityTurnover: 0.9443 epsBasic: 3.2900
epsBasicGrowth: 24.6212 incomeBeforeTaxes: 403.4900
priceEarningsRatioCompany: 32.6596 priceCashFlowRatio: 51.0648
dividendYield: 1.0237 bookValuePerShare: 22.5300
marketCap: 9610389246.5000 earningsYield: 3.0619
pegRatio: 1.3265 cashFlowPerShare: 2.1042
netAssetsPerShare: 22.6976 priceBookValueRatio: 4.7692
dividendsPerShare: 1.1000 priceEarningsRatio: 32.6995
netEarningsPerShare: 3.2860 currency: EUR
year: 2023 units: 1000000
balanceSheetTotal: 3032.9000 cash: 10.6000
currentAssets: 1911.7000 fixedAssets: 1121.2000
liabilities: 561.6000 nonCurrentLiabilities: 298.4000
totalLiabilitiesEquity: 3032.9000 provisions: 71.6000
totalShareholdersEquity: 2159.4000 employees: 4823
property: 315.8000 intangibleAssets: 259.5000
longTermInvestments: 8.6000 inventories: 520.2000
accountsReceivable: 196.6000 accountsPayable: 157.8000
liabilitiesTotal: 860.0100 longTermDebt: 229.9000
shortTermDebt: 46.0000 minorityInterests: 13.5000
sales: 2089.3000 netIncome: 290.4000
operatingResult: 348.1000 incomeInterest: 12.8000
investments: 349.3000 incomeTaxes: 120.6000
costGoodsSold: 883.5000 grossProfit: 1205.8000
minorityInterestsProfit: -1.6000 revenuePerEmployee: 433195.1068
cashFlow: 250.9000 cashFlowInvesting: -111.0000
cashFlowFinancing: -135.1000 accountingStandard: IFRS
equityRatio: 71.1992 debtEquityRatio: 40.4511
liquidityI: 1.8875 liquidityII: 36.8946
netMargin: 13.8994 grossMargin: 57.7131
cashFlowMargin: 12.0088 ebitMargin: 16.6611
ebitdaMargin: 0.0000 preTaxROE: 19.1072
preTaxROA: 13.6041 roe: 13.4482
roa: 9.5750 netIncomeGrowth: -1.1909
revenuesGrowth: 9.7990 taxExpenseRate: 29.2293
equityTurnover: 0.9675 epsBasic: 3.2500
epsBasicGrowth: -1.2158 incomeBeforeTaxes: 412.6000
priceEarningsRatioCompany: 25.4831 priceCashFlowRatio: 29.5236
dividendYield: 1.3282 bookValuePerShare: 24.1434
marketCap: 7407468007.4000 earningsYield: 3.9242
pegRatio: -20.9598 cashFlowPerShare: 2.8052
netAssetsPerShare: 24.2943 priceBookValueRatio: 3.4303
dividendsPerShare: 1.1000 priceEarningsRatio: 25.5078
netEarningsPerShare: 3.2468 currency: EUR
year: 2024 priceEarningsRatioCompany: 18.8308
priceCashFlowRatio: 21.8165 dividendYield: 1.7974
bookValuePerShare: 24.1434 marketCap: 5473762884.0000
earningsYield: 5.3105 pegRatio: -15.4883
cashFlowPerShare: 2.8052 netAssetsPerShare: 24.1434
priceBookValueRatio: 2.5349 priceEarningsRatio: 18.8490
netEarningsPerShare: 3.2468 currency: EUR

Finanzen (ausführlich)

year: 2022
units: 1000000
balanceSheetTotal: 2822.8200
cash: 7.7300
currentAssets: 1791.8500
fixedAssets: 1030.9600
liabilities: 539.3200
nonCurrentLiabilities: 253.4100
totalLiabilitiesEquity: 2822.8200
provisions: 29.3100
totalShareholdersEquity: 2015.1000
employees: 4224
property: 236.1500
intangibleAssets: 240.4300
inventories: 382.7500
accountsReceivable: 197.8000
accountsPayable: 124.3900
liabilitiesTotal: 792.7300
longTermDebt: 91.7700
shortTermDebt: 66.8800
minorityInterests: 14.9900
sales: 1902.8400
depreciation: 69.7700
netIncome: 293.9000
operatingResult: 396.8800
incomeInterest: 4.1500
investments: 291.3700
incomeTaxes: 107.5800
costGoodsSold: 775.2400
grossProfit: 1127.6000
minorityInterestsProfit: -2.0000
revenuePerEmployee: 450482.9545
cashFlow: 188.2000
cashFlowInvesting: -148.8900
cashFlowFinancing: -38.2400
accountingStandard: IFRS
equityRatio: 71.3861
debtEquityRatio: 40.0834
liquidityI: 1.4333
liquidityII: 38.1091
netMargin: 15.4453
grossMargin: 59.2588
cashFlowMargin: 9.8905
ebitMargin: 20.8572
ebitdaMargin: 0.0000
preTaxROE: 20.0233
preTaxROA: 14.2939
roe: 14.5849
roa: 10.4116
netIncomeGrowth: 24.3758
revenuesGrowth: 15.5477
taxExpenseRate: 26.6624
equityTurnover: 0.9443
epsBasic: 3.2900
epsBasicGrowth: 24.6212
incomeBeforeTaxes: 403.4900
priceEarningsRatioCompany: 32.6596
priceCashFlowRatio: 51.0648
dividendYield: 1.0237
bookValuePerShare: 22.5300
marketCap: 9610389246.5000
earningsYield: 3.0619
pegRatio: 1.3265
cashFlowPerShare: 2.1042
netAssetsPerShare: 22.6976
priceBookValueRatio: 4.7692
dividendsPerShare: 1.1000
priceEarningsRatio: 32.6995
netEarningsPerShare: 3.2860
currency: EUR
year: 2023
units: 1000000
balanceSheetTotal: 3032.9000
cash: 10.6000
currentAssets: 1911.7000
fixedAssets: 1121.2000
liabilities: 561.6000
nonCurrentLiabilities: 298.4000
totalLiabilitiesEquity: 3032.9000
provisions: 71.6000
totalShareholdersEquity: 2159.4000
employees: 4823
property: 315.8000
intangibleAssets: 259.5000
longTermInvestments: 8.6000
inventories: 520.2000
accountsReceivable: 196.6000
accountsPayable: 157.8000
liabilitiesTotal: 860.0100
longTermDebt: 229.9000
shortTermDebt: 46.0000
minorityInterests: 13.5000
sales: 2089.3000
netIncome: 290.4000
operatingResult: 348.1000
incomeInterest: 12.8000
investments: 349.3000
incomeTaxes: 120.6000
costGoodsSold: 883.5000
grossProfit: 1205.8000
minorityInterestsProfit: -1.6000
revenuePerEmployee: 433195.1068
cashFlow: 250.9000
cashFlowInvesting: -111.0000
cashFlowFinancing: -135.1000
accountingStandard: IFRS
equityRatio: 71.1992
debtEquityRatio: 40.4511
liquidityI: 1.8875
liquidityII: 36.8946
netMargin: 13.8994
grossMargin: 57.7131
cashFlowMargin: 12.0088
ebitMargin: 16.6611
ebitdaMargin: 0.0000
preTaxROE: 19.1072
preTaxROA: 13.6041
roe: 13.4482
roa: 9.5750
netIncomeGrowth: -1.1909
revenuesGrowth: 9.7990
taxExpenseRate: 29.2293
equityTurnover: 0.9675
epsBasic: 3.2500
epsBasicGrowth: -1.2158
incomeBeforeTaxes: 412.6000
priceEarningsRatioCompany: 25.4831
priceCashFlowRatio: 29.5236
dividendYield: 1.3282
bookValuePerShare: 24.1434
marketCap: 7407468007.4000
earningsYield: 3.9242
pegRatio: -20.9598
cashFlowPerShare: 2.8052
netAssetsPerShare: 24.2943
priceBookValueRatio: 3.4303
dividendsPerShare: 1.1000
priceEarningsRatio: 25.5078
netEarningsPerShare: 3.2468
currency: EUR
year: 2024
priceEarningsRatioCompany: 18.8308
priceCashFlowRatio: 21.8165
dividendYield: 1.7974
bookValuePerShare: 24.1434
marketCap: 5473762884.0000
earningsYield: 5.3105
pegRatio: -15.4883
cashFlowPerShare: 2.8052
netAssetsPerShare: 24.1434
priceBookValueRatio: 2.5349
priceEarningsRatio: 18.8490
netEarningsPerShare: 3.2468
currency: EUR